GSKC Anleihen
Unten befindet sich eine Liste von GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs Unternehmensanleihen. Investoren entscheiden sich oft für Unternehmensanleihen, weil sie eine gesteigerte Stabilität zu Zeiten von erheblichen Marktvolatilitäten bieten. Sehen Sie sich die Preise, Renditen und weitere Daten an. Entdecken Sie eine zuverlässige Investition.
Symbol | YTM % | Volumen | Preis % | Coupon % | Verfallsdatum | Ausstehend | Nennwert | Min. Anlagebetrag | Emittent |
|---|---|---|---|---|---|---|---|---|---|
| GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | — | 4,69 M | 102,36% | 4,88% | 2035-04-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | — | 89 K | 88,94% | 4,20% | 2043-03-18 | 500 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | — | 6 K | 113,02% | 6,38% | 2038-05-15 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | — | 1,1 M | 100,71% | 4,32% | 2027-03-12 | 400 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | — | 6,78 M | 101,88% | 4,50% | 2030-04-15 | 850 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | — | 700 K | 100,28% | 4,86% | 2027-03-12 | 600 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| AAG99GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033 | — | 0 | 103,55% | 5,25% | 2033-12-19 | 574,17 M GBP | 1.000,00 GBP | 1.000,00 GBP | GlaxoSmithKline Capital Plc |
| 117RIGlaxoSmithKline Capital Plc 4.25% 18-DEC-2045 | — | 8,46 K | 82,51% | 4,25% | 2045-12-18 | 370,79 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| 771ZCGlaxoSmithKline Capital Plc 6.375% 09-MAR-2039 | — | 0 | 107,75% | 6,38% | 2039-03-09 | 631,3 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-2028 | — | — | — | 0,88% | 2028-09-21 | 42,5 B JPY | 100.000.000,00 JPY | 100.000.000,00 JPY | GlaxoSmithKline Capital Plc |
| 772WIGlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034 | — | 0 | 105,28% | 5,38% | 2034-04-15 | 500 M USD | 1.000,00 USD | 1.000,00 USD | GlaxoSmithKline Capital, Inc. |
| 883GIGlaxoSmithKline Capital Plc 5.25% 10-APR-2042 | — | 0 | 94,95% | 5,25% | 2042-04-10 | 477,82 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| 117RNGlaxoSmithKline Capital Plc 3.375% 20-DEC-2027 | — | 0 | 112,19% | 3,38% | 2027-12-20 | 307,77 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028 | — | 0 | 91,79% | 1,25% | 2028-10-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030 | — | 0 | 95,17% | 1,75% | 2030-05-21 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381776GSK Capital BV 3.125% 28-NOV-2032 | — | 0 | 99,76% | 3,13% | 2032-11-28 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026 | — | 0 | 98,80% | 1,00% | 2026-09-12 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029 | — | 0 | 97,98% | 3,38% | 2029-06-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028 | — | 0 | 99,90% | 3,88% | 2028-05-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS293369143GSK Capital BV 2.875% 19-NOV-2031 | — | 0 | 99,15% | 2,88% | 2031-11-19 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035 | — | 0 | 73,21% | 1,63% | 2035-05-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026 | — | 0 | 99,40% | 1,25% | 2026-05-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK Capital BV 3.0% 28-NOV-2027 | — | 0 | 101,16% | 3,00% | 2027-11-28 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS293369275GSK Capital BV 3.25% 19-NOV-2036 | — | 0 | 97,66% | 3,25% | 2036-11-19 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029 | — | 0 | 95,13% | 1,38% | 2029-09-12 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |